GNW-Adhoc: Idorsia announces changes to Idorsia Executive Committee and Board of Directors finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.
Ad hoc announcement pursuant to Art. 53 LR Jean-Paul Clozel to retire as CEO and stand for election as Chairman of the Board of DirectorsMathieu Simon to stand for re-election to the Board - taking
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) and Jasper Therapeutics (NASDAQ:JSPR – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, earnings and analyst recommendations. Profitability This table compares Neurocrine Biosciences and Jasper […]
Idorsia Pharmaceuticals Ltd: Bondholders approve amended terms of the 2024 convertible bonds finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.